Stock 1889 SANAI HEALTH INDUSTRY GROUP COMPANY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Sanai Health Industry Group Company Limited

Equities

1889

KYG7785S1075

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:20 2024-04-26 am EDT 		5-day change 1st Jan Change
0.026 HKD -10.34% Intraday chart for Sanai Health Industry Group Company Limited -7.14% -59.38%
Apr. 18 Sanai Health Unit to Offload 59% Stake in Genetic Testing Provider MT
Apr. 17 Zhou Chen agreed to acquire 59% stake in Zentrogene Bioscience Laboratory Limited from Sanai Health Industry Group Company Limited for HKD 22 million. CI

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 593.3 875.3 260.4 232.3 312.4 225.8
Enterprise Value (EV) 1 813.5 1,074 243.9 218.2 295.6 274.9
P/E ratio -0.43 x -3.7 x 2.39 x 36.2 x 34.6 x 7.9 x
Yield - - - - - -
Capitalization / Revenue 9.49 x 13.7 x 3.18 x 1.91 x 4.62 x 1.28 x
EV / Revenue 13 x 16.7 x 2.98 x 1.8 x 4.37 x 1.56 x
EV / EBITDA -39.1 x -19.1 x -10.9 x 11.3 x 10.5 x 4.39 x
EV / FCF -3.07 x -37.9 x 1.76 x -1.69 x 2.86 x -1.86 x
FCF Yield -32.6% -2.64% 56.9% -59.3% 35% -53.7%
Price to Book 2.71 x 12.2 x 1.45 x 1.23 x 1.57 x 0.92 x
Nbr of stocks (in thousands) 2,872,123 3,067,223 3,067,223 3,067,223 3,067,223 3,196,223
Reference price 2 0.2066 0.2854 0.0849 0.0757 0.1019 0.0707
Announcement Date 4/27/18 4/30/19 7/30/21 7/30/21 4/29/22 4/28/23
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 62.53 64.12 81.85 121.4 67.61 175.9
EBITDA 1 -20.82 -56.13 -22.42 19.34 28.14 62.59
EBIT 1 -101 -70.9 -25.24 15.85 24.72 59.35
Operating Margin -161.58% -110.56% -30.84% 13.06% 36.57% 33.73%
Earnings before Tax (EBT) 1 -1,035 -183.7 -40.06 16.65 25.5 55.77
Net income 1 -1,152 -229.8 109 6.422 9.025 29.22
Net margin -1,841.79% -358.3% 133.11% 5.29% 13.35% 16.61%
EPS 2 -0.4783 -0.0771 0.0355 0.002093 0.002942 0.008946
Free Cash Flow 1 -265.3 -28.32 138.8 -129.3 103.3 -147.7
FCF margin -424.28% -44.17% 169.52% -106.54% 152.81% -83.93%
FCF Conversion (EBITDA) - - - - 367.19% -
FCF Conversion (Net income) - - 127.36% - 1,144.75% -
Dividend per Share - - - - - -
Announcement Date 4/27/18 4/30/19 7/30/21 7/30/21 4/29/22 4/28/23
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 220 198 - - - 49
Net Cash position 1 - - 16.5 14.1 16.8 -
Leverage (Debt/EBITDA) -10.58 x -3.532 x - - - 0.7834 x
Free Cash Flow 1 -265 -28.3 139 -129 103 -148
ROE (net income / shareholders' equity) -158% -158% -30.6% 5.91% 8.02% 14.8%
ROA (Net income/ Total Assets) -6.58% -9.88% -5.1% 3.64% 5.13% 10.7%
Assets 1 17,502 2,325 -2,138 176.3 175.8 274.1
Book Value Per Share 2 0.0800 0.0200 0.0600 0.0600 0.0600 0.0800
Cash Flow per Share 2 0.0200 0.0100 0 0 0.0100 0.0100
Capex 1 205 - 1.87 1.1 0.07 0.03
Capex / Sales 327.04% - 2.28% 0.91% 0.11% 0.02%
Announcement Date 4/27/18 4/30/19 7/30/21 7/30/21 4/29/22 4/28/23
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
SANAI HEALTH INDUSTRY GROUP COMPANY LIMITED Stock Sanai Health Industry Group Company Limited
-59.38% 12.7M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 1889 Stock
  4. Financials Sanai Health Industry Group Company Limited